Sungnam-si, South Korea

Soo-il Chung


Average Co-Inventor Count = 4.5

ph-index = 3

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2002-2010

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Soo-il Chung

Introduction

Soo-il Chung is a prominent inventor based in Sungnam-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of immunologically active proteins and angiogenesis inhibitors. With a total of five patents to his name, his work has the potential to impact both human and animal health.

Latest Patents

One of his latest patents involves detoxified and immunologically active proteins known as mutant LTs. These proteins have mutated amino acid sequences of heat-labile enterotoxin and are designed to be used as immunogenic antigens for vaccination. Unlike the wild-type LT, the mutant LTs do not induce toxic activities, making them safer for use. They have shown the ability to elicit high levels of anti-LT antibodies, which could be beneficial in developing a novel diarrheal vaccine.

Another significant patent is for a novel angiogenesis inhibitor named LK68. This protein is identical to the human apolipoprotein (a) kringle domains and has shown promise as an anticancer agent. LK68 inhibits endothelial cell proliferation and migration, which are critical processes in tumor growth and angiogenesis. The systemic administration of LK68 has been correlated with the inhibition of primary tumor growth, indicating its potential application in treating various angiogenesis-mediated diseases.

Career Highlights

Soo-il Chung has worked with notable organizations such as Mogam Biotechnology Research Institute and Green Cross Vaccine Corporation. His experience in these institutions has allowed him to advance his research and contribute to significant innovations in biotechnology.

Collaborations

Throughout his career, Soo-il Chung has collaborated with several professionals, including Jihoon Chang and Jang Seong Kim. These collaborations have likely enriched his research and led to the development of impactful inventions.

Conclusion

Soo-il Chung's innovative work in biotechnology, particularly in the areas of immunologically active proteins and angiogenesis inhibitors, showcases his significant contributions to science and medicine. His patents hold promise for advancing healthcare solutions for various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…